Elevated plasma homocysteine levels in patients treated with levodopa: association with vascular disease.

This is the first report that levodopa-related hyperhomocysteinemia is associated with increased risk for coronary artery disease (CAD), and the findings have implications for the treatment of PD in patients at risk for vascular disease, and potentially for those at risk of dementia and depression.